Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Melanoma 5 Lymphoma, Follicular 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Waldenstrom Macroglobulinemia 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

pembrolizumab 23 Nivolumab 22 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Dacarbazine 6 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Biopsy 5 Aminolevulinic Acid 5 encorafenib 4 dabrafenib 4 Photochemotherapy 4 Educational Status 4 trametinib 3 sonidegib 3 montanide ISA 51 3 avelumab 3 Tacrolimus 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Neoplasms × oblimersen × Clear all

NCT00518895 2011-11-07

AGENDA

Genta Incorporated

Phase 3 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡